It was identified that circ-ERBIN was elevated in CRC, and it promotes colorectal cancer growth and metastasis by mediating HIF-1α through miR-125a-5p and miR-138-5p, suggesting that circ-ERBIN is a potential target for CRC treatment26. This evidence concerns the gene HIF1A and colorectal carcinoma.